Analytical Data
-
Gene name
TARS
- Application
-
Alternative Names
ThrRS; PL-7; PL7; Threonine tRNA Ligase 1,Cytoplasmic
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P26639
-
Expression Region
Met1~Ile300
-
Molecular Weight
40kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TARS (Threonyl-tRNA Synthetase) is a crucial enzyme in protein biosynthesis, catalyzing the attachment of threonine to its corresponding tRNA molecule. Its significance extends beyond this essential role; TARS is also implicated in various cellular processes and diseases. Recent studies have highlighted its involvement in mitochondrial function and the stress response, suggesting that TARS may play a role in conditions such as cancer and neurodegenerative disorders. The study of TARS is further motivated by its potential as a therapeutic target, especially given the rising interest in precision medicine and targeted therapies. With its dual functionality, understanding TARS and developing recombinant proteins that can modulate its activity could yield insights into its biochemical pathways and provide innovative strategies for disease intervention. The recombinant protein research surrounding TARS thus aims to elucidate its structural and functional mechanisms, paving the way for novel treatments that could manipulate its enzymatic activity for therapeutic benefits.
